Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: The GO-FORWARD Study
Keystone, E. C.; Genovese, M. C.; Klareskog, L.; Hsia, E. C.; Hall, S. T.; Miranda, P. C.; Pazdur, J.; Bae, S. C.; Palmer, W.; Zrubek, J.; Wiekowski, M.; Visvanathan, S.; Wu, Z.; Rahman, M. U. (2009)